Literature DB >> 35007523

Long non-coding RNAs in gastrointestinal cancers: Implications for protein phosphorylation.

Tao Su1, Teng Wang1, Nasha Zhang2, Yue Shen1, Wenwen Li2, Huaixin Xing3, Ming Yang4.   

Abstract

Phosphorylation of proteins is one of the most extensively investigated post-translational protein modifications. Threonine, serine and tyrosine in proteins are the most commonly phosphorylated amino acids. Dysregulated cancer-related signaling pathways due to aberrant phosphorylation status of the key protein(s) in these pathways exist in most malignancies. Intensive studies in the recent decade have implicated long non-coding RNAs (lncRNAs) in the precise regulation of protein phosphorylation in cancers. In this review, we systematically delve into recent advance that underlines the multidimensional role of lncRNAs in modulating protein phosphorylation, regulating cancerous signaling and impacting prognosis of gastrointestinal (GI) cancers including hepatocellular carcinoma, colorectal cancer, gastric cancer, esophageal cancer, and pancreatic cancer. LncRNAs regulate protein phosphorylation via directly binding to the target protein(s), interacting with the partner protein(s) of the target protein(s) or lncRNAs-encoded small peptides. Although there are still extensive studies on disclosing the intricate interactions between lncRNAs and proteins and their impacts on protein phosphorylation, we believe that targeting lncRNAs controlling phosphorylation of key protein(s) in cancerous signaling pathways might provide novel paths for precision therapeutics of GI cancers in the future.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastrointestinal cancer; Oncogene; Protein phosphorylation; Tumor suppressor; lncRNAs

Mesh:

Substances:

Year:  2022        PMID: 35007523     DOI: 10.1016/j.bcp.2022.114907

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  2 in total

1.  Integrated Analysis of miR-7-5p-Related ceRNA Network Reveals Potential Biomarkers for the Clinical Outcome of Gastric Cancer.

Authors:  Meng-Yang Shi; Yan-Fei Mu; Neng Shen
Journal:  J Oncol       Date:  2022-02-14       Impact factor: 4.501

2.  The Novel LncRNA WASH5P Inhibits Colorectal Cancer Carcinogenesis via Targeting AKT Signaling Pathway.

Authors:  Hongyun Wei; Tao Mao; Qian Zhang; Keyu Ren; Xingsi Qi; Yunmei Zhang; Bin Cao; Yanchun Jin; Zibin Tian; Linlin Ren
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.